NASDAQ:TARS | Income Statement | Tarsus Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$173.91M$12.11M$31.01M$150.7M-$19.91M$4.07M$2.72M-$18.55M-$0.43-$0.4343,393,64343,393,643
2026-03-31$162.05M$9.4M$22.35M$136.43M-$6.12M$1.51M$2.35M-$6.97M-$0.16-$0.1642,956,97342,956,973
2025-12-31$151.67M$18.04M$130.68M-$7.98M$1.66M-$8.37M-$0.19-$0.19326,987326,987
2025-09-30$118.7M$16.28M$108.63M-$14.53M$1.94M-$12.59M-$0.30-$0.3042,607,71742,607,717
2025-06-30$102.66M$6.24M$15.59M$103.01M-$22.18M$1.84M$0.00-$20.34M-$0.48-$0.4842,360,45242,360,452
2025-03-31$78.34M$5.21M$14.41M$85M-$26.28M$1.16M$0.00-$25.12M-$0.64-$0.6439,345,35939,345,359
2024-12-31$66.41M$16.87M$69.03M-$24.42M$1.31M-$23.11M-$0.59-$0.59317,627317,627
2024-09-30$48.12M$12.13M$57.91M-$25.16M$1.74M-$23.42M-$0.61-$0.6138,381,96838,381,968
2024-06-30$40.81M$12.32M$58.79M-$33.3M$12,000.00-$33.29M-$0.88-$0.8837,823,23337,823,233
2024-03-31$27.61M$12.07M$51.58M-$37.68M$1.95M-$35.73M-$1.01-$1.0135,300,65535,300,655
2023-12-31$13.08M$13.31M-$44.45M$2.55M$0.00-$41.9M-$1.27-$1.271,317,8421,317,842
2023-09-30$1.87M$12.11M-$40.94M$1.79M$0.00-$39.15M-$1.28-$1.2830,622,44030,622,440
2023-06-30$0.00$0.00$12.55M-$32.82M$1.4M$0.00-$31.42M-$1.17-$1.1726,815,73326,815,733
2023-03-31$2.5M$0.00$12.36M-$24.95M$1.53M$0.00-$23.42M-$0.88-$0.8826,742,02326,742,023
2022-12-31$10M$10.03M-$15.06M$1.46M$0.00-$13.6M-$0.49-$0.49696,188696,188
2022-09-30$0.00$0.00$10.91M-$22.91M$390,000.00-$5,000.00-$22.51M-$0.84-$0.8426,662,37426,662,374
2022-06-30$15.28M$522,000.00$9.6M$20.5M-$5.22M-$519,000.00$0.00-$5.74M-$0.24-$0.2424,332,53124,332,531
2022-03-31$539,000.00$33,000.00$12.08M$20.06M-$19.52M-$716,000.00$1,000.00-$20.24M-$0.98-$0.9820,710,22420,710,224
2021-12-31$338,000.00$8.04M$14.79M-$14.45M-$349,000.00$54,000.00-$14.85M-$0.72-$0.7242,113-1,478,401
2021-09-30$1.24M$65,000.00$10.21M$16.95M-$15.71M-$333,000.00-$341,000.00-$15.7M-$0.76-$0.7620,641,28520,641,285
2021-06-30$22.02M$7.2M$14.74M$7.28M-$908,000.00$29,000.00$6.35M$0.31$0.2920,555,25821,966,599
2021-03-31$33.43M$16.26M$22.72M$10.71M-$25,000.00$313,000.00$10.38M-$0.51$0.4720,336,02221,824,574
2020-12-31$0.00$7.59M$11.48M-$11.48M$10,000.00$0.00-$11.47M$1.41$1.413,530,0523,530,052
2020-09-30$0.00$7.99M$10.14M-$10.14M$4,000.00$1,000.00-$10.14M-$3.71-$3.712,729,6852,729,685
2020-06-30$0.00$1.74M$3.26M-$3.26M$13,000.00$0.00-$3.25M-$1.23-$1.232,651,3212,651,321
2020-03-31$0.00$1.51M$2.12M-$2.12M$161,000.00$0.00-$1.96M-$0.74-$0.742,650,3632,650,363
2019-12-31$697,000.00$1.08M-$1.08M-$328,000.00$0.00-$1.41M50,980
2019-09-30$399,000.00$633,000.00-$633,000.00-$48,000.00$0.00-$681,000.002,471,237
2019-06-30-$831,000.00
2019-03-31-$1.75M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$451.36M$64.32M$427.32M-$70.97M$6.61M-$64.36M$2.06M-$66.42M-$1.59-$1.5941,784,01441,784,014
2024-12-31$182.95M$53.39M$237.31M-$120.57M$5.02M-$115.55M$0.00-$115.55M-$3.07-$3.0737,604,53837,604,538
2023-12-31$17.45M$50.31M$108.7M$160.61M-$143.16M$7.27M-$135.89M$0.00-$135.89M-$4.62-$4.6229,383,27629,383,276
2022-12-31$25.82M$42.62M$44.95M$88.53M-$62.71M$617,000.00-$62.1M-$4,000.00-$62.09M-$2.52-$2.5224,619,70024,619,700
2021-12-31$57.03M$41.71M$69.18M-$12.16M-$1.62M-$13.77M$55,000.00-$13.83M-$0.67-$0.6720,554,08620,554,086
2020-12-31$0.00$18.83M$27M-$27M$188,000.00-$26.81M$1,000.00-$26.81M-$4.32-$4.326,207,3676,207,367
2019-12-31$3.16M$4.3M-$4.3M-$371,000.00$1,000.00-$4.67M2,362,768
2018-12-31-$1.32M